Resources

Type of publications
Regions
Diseases

5255 results found

2024 ∙ Mektebi, A. Elsaid, M. Yadav, T. Abdallh, F. Assker, M. Siddiq, A. Sayad, R. Saifi, M. Farahat, R. A.

Mpox vaccine acceptance among healthcare workers: a systematic review and meta-analysis

  • Healthcare workers
  • Mpox
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Mason, L. M. K. Betancur, E. Riera-Montes, M. Lienert, F. Scheele, S.

MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings

  • All age groups
  • Mpox
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Choi, Y. Lee, J. S. Choe, Y. J. Lee, H. Yoon, Y. Shin, S. H. Hwang, M. J. Choi, H. Na, S. Kim, J. H. Kang, H. M. Ahn, B. Seo, K. Park, S.

Myocarditis and Pericarditis are Temporally Associated with BNT162b2 COVID-19 Vaccine in Adolescents: A Systematic Review and Meta-analysis

  • Newborn
  • Children
  • Adolescents
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Ling, R. R. Grignani, R. Ling, M. R. Thenpandiyan, A. A. Tai, B. C. Somani, J. Ramanathan, K. Quek, S. C.

Myopericarditis following COVID-19 vaccination in children: a systematic review and meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Moderate
2024 ∙ Oliveira, J. A. Silva, E. G. Karasu, A. F. G. Silva, A. M. N. Philip, C. E.

Neonatal and Maternal Outcomes of mRNA Compared With Non-mRNA Vaccinations in Pregnant Patients With COVID-19: A Systematic Review and Meta-Analysis

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Mashkoor, Y. Nadeem, A. Fatima, T. Aamir, M. Vohra, L. I. Habib, A. Khan, A. Raufi, N. Habte, A.

Neurological complications of influenza vaccination: Navigating the spectrum with a focus on acute disseminated encephalomyelitis (ADEM)

  • Children
  • Adolescents
  • Adults
  • Older adults
  • Influenza
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Vieira, I. S. A. da Rocha, F. M. Vilarim, M. Rebelo, F. Marano, D.

Neutralizing antibodies in milk and blood of lactating women vaccinated for SARS-CoV-2: a systematic review

  • Parents/caregivers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Wu, P. C. Huang, I. H. Wang, C. Y. Chi, C. C.

New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review

  • Children
  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Ghanaatpisheh, A. Safari, M. Haghshenas, H. Motamed-Sanaye, A. Atefi, A. H. Kamangarpour, K. Bagherzadeh, M. A. Kamran-Jahromi, A. Darayesh, M. Kouhro, N. Bahadori, A. R. Esfandiari, M. A.

New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: a systematic review of case report and case series studies

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Lazareva, M. Renemane, L. Vrublevska, J. Rancans, E.

New-onset psychosis following COVID-19 vaccination: a systematic review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...